Connect Biopharma Holdings Limited - American Depositary Shares — Quarterly Financial Statistics (NASDAQ:CNTB) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -2.32 M-9.96 M-12.59 M-17.41 M-11.25 M -51.21 M Cash from investing activities -15.76 M-20.64 M5.13 M14.35 M10.98 M 9.82 M Cash from financing activities 106 K2 000161 K215 K715 K 1.09 M Free cash flow -2.63 M-10.04 M-12.89 M-17.44 M-11.27 M -51.64 M

뉴스

Connect Biopharma Holdings Limited (CNTB) Discusses Phase 3 Atopic Dermatitis Study Results and Updates on Rademikibart Development Transcript

Simcere’s rademikibart AD study selected for AAD presentation

Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript

코넥트 바이오파마, BTIG ’매수’ 등급 개시…호흡기 약물 잠재력

Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential

This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX)

코넥트 바이오파마, H.C. Wainwright ’매수’ 등급 유지

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target

Connect Biopharma Posts Q2 Revenue Drop

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?

Connect Biopharma stock rating reiterated as Outperform by Northland

Connect Biopharma appoints Jim Schoeneck to board of directors